(Circulation. 1995;92:2572-2578.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Anesthesia (B.W.B., J.M., H.B., T.B., E.M.), Clinical Laboratory at the Department of Surgery (M.A.), and the Department of Internal Medicine (P.P.N.), University of Heidelberg (Germany).
Correspondence to Bernd W. Böttiger, MD, DEAA, Department of Anesthesia, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany.
Background Animal studies have demonstrated that hemostatic disorders occurring after cardiac arrest affect outcome. We investigated hemostatic changes during and after cardiopulmonary resuscitation (CPR) in humans.
Methods and Results The prospective study included 23 patients (29 to 86 years) who underwent out-of-hospital CPR for nontraumatic causes. Blood samples were drawn immediately and 15 and 30 minutes after initiation of CPR. In the case of restoration of spontaneous circulation (ROSC; n=7), additional blood samples were taken immediately, 30 minutes, and 2, 8, 24, 48, and 72 hours after ROSC. A marked activation of blood coagulation was found in all patients. The specific markers of activated blood coagulation and fibrin formation, thrombin-antithrombin complex (TAT; median during CPR, 260 µg/L; median after ROSC, 57 µg/L; normal range, 1.0 to 4.1 µg/L), and fibrin monomers (FM; median during CPR, 34.3 µg/mL; median after ROSC, 65.4 µg/mL; normal range, 0 to 3.6 µg/mL) were markedly increased during and in the early phase after CPR. When patients survived for 48 hours, TAT and FM values returned to the normal range. In most patients, the plasma levels of D-dimer, an indicator of endogenous fibrinolytic activity, were not markedly increased during CPR (median, <0.25 µg/mL; normal range, <0.25 µg/mL) but increased moderately after ROSC (median, 0.56 µg/mL). Levels of plasminogen activator inhibitor type 1 (normal range, 0.3 to 3.5 U/mL), a marker for endogenous inhibition of fibrinolytic activity, were moderately increased in most patients (median during CPR, 4.22 U/mL; median after ROSC, 8.08 U/mL).
Conclusions Our data clearly demonstrate that there is a marked activation of blood coagulation and fibrin formation after prolonged cardiac arrest and CPR in humans that is not balanced adequately by concomitant activation of endogenous fibrinolysis. These changes may contribute to reperfusion disorders, such as the cerebral "no-reflow" phenomenon, by inducing fibrin deposition and formation of microthrombi.
Key Words: cardiopulmonary resuscitation circulation coagulation men reperfusion
This article has been cited by other articles:
![]() |
A. Schneider, B. W. Bottiger, and E. Popp Cerebral Resuscitation After Cardiocirculatory Arrest Anesth. Analg., March 1, 2009; 108(3): 971 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Bottiger, H.-R. Arntz, D. A. Chamberlain, E. Bluhmki, A. Belmans, T. Danays, P. A. Carli, J. A. Adgey, C. Bode, V. Wenzel, et al. Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest N. Engl. J. Med., December 18, 2008; 359(25): 2651 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Neumar, J. P. Nolan, C. Adrie, M. Aibiki, R. A. Berg, B. W. Bottiger, C. Callaway, R. S.B. Clark, R. G. Geocadin, E. C. Jauch, et al. Post-Cardiac Arrest Syndrome: Epidemiology, Pathophysiology, Treatment, and Prognostication A Consensus Statement From the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council Circulation, December 2, 2008; 118(23): 2452 - 2483. [Full Text] [PDF] |
||||
![]() |
D K Pedley and W G Morrison Role of thrombolytic agents in cardiac arrest. Emerg. Med. J., October 1, 2006; 23(10): 747 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Sheth, P Cullinan, V Vachharajani, and S A Conrad Bolus thrombolytic infusion during prolonged refractory cardiac arrest of undiagnosed cause Emerg. Med. J., March 1, 2006; 23(3): e19 - e19. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Adrie, M. Monchi, I. Laurent, S. Um, S. B. Yan, M. Thuong, A. Cariou, J. Charpentier, and J. F. Dhainaut Coagulopathy After Successful Cardiopulmonary Resuscitation Following Cardiac Arrest: Implication of the Protein C Anticoagulant Pathway J. Am. Coll. Cardiol., July 5, 2005; 46(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Adrie, M. Adib-Conquy, I. Laurent, M. Monchi, C. Vinsonneau, C. Fitting, F. Fraisse, A. T. Dinh-Xuan, P. Carli, C. Spaulding, et al. Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a "Sepsis-Like" Syndrome Circulation, July 30, 2002; 106(5): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Becker, M. L. Weisfeldt, M. H. Weil, T. Budinger, J. Carrico, K. Kern, G. Nichol, I. Shechter, R. Traystman, C. Webb, et al. The PULSE Initiative: Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapies Circulation, May 28, 2002; 105(21): 2562 - 2570. [Full Text] [PDF] |
||||
![]() |
D. M. Poullis, V. Wenzel, K. H. Lindner, A. C. Krismer, E. A. Miller, W. G. Voelckel, and W. Lingnau Repeated Administration of Vasopressin but Not Epinephrine Maintains Coronary Perfusion Pressure After Early and Late Administration During Prolonged Cardiopulmonary Resuscitation in Pigs Response Circulation, April 25, 2000; 101 (16): e174 - e175. [Full Text] [PDF] |
||||
![]() |
H. Okada, J. Woodcock-Mitchell, J. Mitchell, T. Sakamoto, K. Marutsuka, B. E. Sobel, and S. Fujii Induction of Plasminogen Activator Inhibitor Type 1 and Type 1 Collagen Expression in Rat Cardiac Microvascular Endothelial Cells by Interleukin-1 and Its Dependence on Oxygen-Centered Free Radicals Circulation, June 2, 1998; 97(21): 2175 - 2182. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |